RENAISSANCE TECHNOLOGIES LLC

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 1037389 NEW YORK, NY

Position in ATNM

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$469,242

-$62,224 QoQ

Shares Held

471,600

+20.7% QoQ

Ownership

1.50%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. ATNM ranks #231 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$469,242	471,600	+20.7%	Shares	Sole	2026-05-14
2025-12-31	$531,466	390,784	+35.4%	Shares	Sole	2026-02-12
2025-09-30	$461,808	288,630	+37.8%	Shares	Sole	2025-11-13
2025-06-30	$293,301	209,501	+263.7%	Shares	Sole	2025-08-13
2025-03-31	$92,736	57,600	-69.7%	Shares	Sole	2025-05-14
2024-12-31	$239,904	190,400	+49.9%	Shares	Sole	2025-02-13
2024-09-30	$238,760	127,000	+561.5%	Shares	Sole	2024-11-13
2024-06-30	$142,080	19,200	-60.3%	Shares	Sole	2024-08-09
2023-06-30	$358,400	48,302	-52.7%	Shares	Sole	2023-08-11
2023-03-31	$965,790	102,200	-36.0%	Shares	Sole	2023-05-12
2022-12-31	$1,699,740	159,600	+103.8%	Shares	Sole	2023-02-13
2022-09-30	$577,854	78,300	+35.7%	Shares	Sole	2022-11-14
2022-06-30	$277,537	57,700	—	Shares	Sole	2022-08-12
No filing history on record for this holder in this stock.